Zaya AI

Deal Details

BullPerks Announces an IDO Deal with Zaya AI

Pathology, the study of diseases through examining body tissues and fluids, has traditionally depended on manual processes and conventional microscopy techniques. However, as diseases grow increasingly complex and technology rapidly evolves, the demand for more efficient and precise diagnostic methods has intensified. Zaya AI harnesses the power of artificial intelligence to transform the pathology field. To contribute to the development in this field, BullPerks is hosting an Initial DEX Offering (IDO) with Zaya AI, a project that streamlines diagnostic workflows, enhances accuracy, and unlocks new frontiers in disease detection and analysis.

About Zaya AI

Zaya AI works on combating cancer through an innovative ecosystem. By seamlessly integrating the latest AI technologies with state-of-the-art medical screening procedures, they strive to revolutionize early detection, prevention, and treatment strategies. This comprehensive approach holds the promise of saving countless lives by identifying and addressing malignancies at their earliest stages when intervention is most effective.

Zaya AI Main Features

ZayaAI stands as a technology company at the forefront of artificial intelligence, dedicated to delivering comprehensive pathology diagnosis solutions. Leveraging deep computational prowess and extensive medical expertise, the team develops robust and versatile diagnostic tools tailored for the pathology domain.

Reduce diagnosis time
Decrease labs costs
Reduce human error and improve patient outcomes

The comprehensive Zaya AI ecosystem consists of the following components.

Zaya Dx

Zaya AI's pioneering approach harnesses the power of data to drive innovation in the field of pathology. By tapping into a vast repository of annotated data, comprising millions of samples meticulously curated through their proprietary and crowd-sourced pathology network, they possess an invaluable resource. This wealth of information, combined with our extensive library of archived data, enables the team to rigorously train and validate their cutting-edge AI-based models. This data-driven methodology allows Zaya AI to deliver quality and transformative tools that empower pathologists with unprecedented capabilities. The solutions are designed to streamline diagnostic workflows, significantly reducing the time required for critical analysis while simultaneously enhancing confidence in the accuracy of diagnoses. By accelerating these crucial processes, Zaya AI aims to expedite the delivery of life-saving therapies to patients, ensuring timely access to the care they need.

Zaya Telepathology Dx

Zaya AI Telepathology Dx solution is a game-changer in the field of pathology. It enables seamless remote access, second opinion diagnosis, and collaboration, regardless of geographical barriers. This cutting-edge platform empowers pathologists and researchers to access and analyze digital pathology images from anywhere, at any time, improving diagnostic quality and enhancing patient outcomes. With Telepathology Dx, the boundaries of location become irrelevant, as professionals can seamlessly collaborate and consult with specialists across the globe. This streamlined access to external expertise facilitates efficient second opinion readings, shortens waiting times for patients, and ensures they receive timely and accurate diagnoses. By leveraging the power of remote collaboration, Telepathology Dx not only improves diagnostic accuracy but also helps healthcare providers meet patient demand and regulatory compliance more effectively. The platform's user-friendly interface and robust security measures ensure a seamless and secure experience, fostering a collaborative environment that prioritizes patient care.

Zaya Pathology LIS

Using ZayaAI’s all-in-one pathology LIS allows you to streamline an array of lab operations, increase efficiency, and speed up your research outcomes, saving you time and money. ZayaAI Pathology LIS centralizes everything, so you don't have to use separate systems for different functions (inventory management, record keeping, data analysis, etc.) allowing you to transfer information between them. With it, specialists and patients get the following benefits:

Monitor the status of any specimen, anywhere, anytime
Pinpoint where your specimen is immediately
Protect your intellectual property
Share data with your lab members seamlessly
Maintain data integrity & ensure regulatory compliance
Derive insights from your research with the ZayaAI Dashboard
Automate processes and create workflows
Increase productivity and reduce human error
Optimise staff resource allocation
Set high standards of data management

Why Should You Invest in Zaya AI?

Zaya AI is an AI-focused technology company offering comprehensive pathology diagnosis solutions. Leveraging deep computational and medical expertise, the team develops robust and versatile tools for pathology diagnosis. Zaya’s AI-based models are rigorously trained and validated using a vast dataset comprising millions of annotated samples from the company’s proprietary and crowd-sourced pathology network, as well as an extensive library of archived data. This data-driven approach allows specialists to deliver high-quality and transformative tools for pathologists.

The Team Behind Zaya AI

Zaya AI is possible thanks to the great minds that transform the medical field by leveraging the most advanced technologies. Here are those who lead the innovation.

Board of Directors

Cristian Mogodici, Co-Founder & CEO ZAYA AI: Driven by a passion to revolutionize the field of pathology, Cristian's motivation stems from a desire to bridge the gap between cutting-edge AI technology and pathology science. His ambition is to develop high-performing software solutions that provide more accurate diagnoses and ultimately improve patient outcomes. In recent years, Cristian has dedicated himself to the development of novel AI models specifically tailored for pathology diagnosis. His expertise lies in harnessing the power of artificial intelligence to unlock new frontiers in disease detection and analysis. As the co-founder and CEO of a rapidly growing HealthTech startup, Cristian has gained invaluable experience in various critical aspects of business operations. From funding strategies to R&D initiatives, go-to-market approaches, and product management, his leadership has been instrumental in driving the company's growth.

Prof. Dr. Sabina Zurac, MD, Phd: Sabina Zurac is a distinguished senior pathologist with an impressive 27-year career in the field. Currently serving as a Professor of Pathology, Vice Dean of Research in the Faculty of Dental Medicine, and Head of the Department of Pathology at Colentina University Hospital, she has established herself as a leading authority in the discipline. Sabina's expertise encompasses a wide range of areas, including dermatopathology, oral pathology, soft tissue tumors, and infectious disease pathology. Her contributions to the field have been widely recognized, with an exceptional record of 350 presentations and posters at national and international congresses and symposia. In addition to her extensive research and academic work, Sabina has authored or co-authored an impressive 155 scientific papers, with 71 of them published in prestigious ISI-indexed journals. Her dedication to advancing knowledge in the field is further evident in the 26 books and book chapters she has authored.

Board of Advisors

Carolina Alarco, Founder Bio Strategy: Carolina is the founder and principal of Bio Strategy Advisors, a strategic advisory firm based in Cambridge, Massachusetts. With over 25 years of experience in the biopharmaceutical industry, she is a dynamic and seasoned biotech executive whose expertise spans multiple facets of the business.

Cătălina Klumpner, CEO Medist Life Science: CEO Medist Life Science – Leica distributor in Romania.

Martin Lammens, MD, PhD: Dr. Martin Lammers is a highly accomplished and esteemed pathologist and neuropathologist, boasting an impressive 40-year career in the field. Currently holding the distinguished title of Professor Emeritus of Pathology at Antwerp University, Dr. Lammers has dedicated his professional life to advancing the understanding and diagnosis of various medical conditions.

Aleodor Andea, Prof.: Professor of Pathology and Dermatology at the University of Michigan Health System at Michigan Medicine, Ann Arbor, US

Christoph Westerteicher: Former International Business Director, Philips Hospital to Home. Heather Couture, Senior Machine Learning: Senior Machine Learning Advisor. Heather is a Machine Learning Consultant and Founder of Pixel Scientia Labs. She has two decades of experience in computer vision and machine learning, half of those with applications related to pathology.

How to Join Zaya AI IDO on BullPerks?

Are you a newbie and have never participated in the IDO deals on BullPerks? In this comprehensive tutorial, you will find everything you need to know to activate the tier on BullPerks and start investing in deals on our platform. Here are several steps to get started:

Create a wallet

Activate your tier on BullPerks:

Buy $BLP tokens

Lock in $BLP tokens on the platform

Join the IDO deal on BullPerks

You can also stake and farm your $BLP tokens to activate your tier. Read more in this step-by-step guide to investing with BullPerks.

Disclaimer

This material should not be construed as a basis for making investment decisions or as a recommendation to participate in investment transactions. Trading digital assets may involve significant risks and can result in the loss of invested capital. Therefore, you must ensure that you fully understand the risk involved, consider your level of experience and investment objectives, and seek independent financial advice if necessary.

FAQ

How does Zaya AI stand out from other similar projects?
Zaya AI is at the forefront of the battle against cancer, pioneering an innovative ecosystem that integrates cutting-edge AI technologies with state-of-the-art medical screening procedures. Their mission is to revolutionize early detection, prevention, and treatment strategies, offering a comprehensive approach to combat this devastating disease.
Why shall I invest in Zaya AI?
By seamlessly combining the power of AI with advanced screening methodologies, Zaya AI aims to identify and address malignancies at their earliest stages, when intervention is most effective. This groundbreaking approach holds the promise of saving countless lives by enabling timely and targeted treatment, significantly improving patient outcomes. Considering this, investment in Zaya AI may be one of the wisest decisions.
How can I participate in the Zaya AI IDO?
On BullPerks, you can participate in the Zaya AI IDO. To start with, you need to register an account with us, pass KYC, and stake a certain amount of tokens. Based on the staked amount, you are assigned a tier based on which you can participate in the most promising IDO projects.

Zaya AI$ZAYA

Network

BNB Chain

Launch Date

TBA

Total Raise

TBA

End

TBA

Type

IDO

Min Allocation

TBA

Max Allocation

TBA

Vesting

20% upfront, 1 mo Cliff, 5 mo vesting

Token Price

0.15